Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 17 Nov 2011 |
| Multiple Data for Ofatumumab and Daratumumab to be presented at ASH | 8 Nov 2011 |
| Genmab Announces Financial Results for the First Nine Months of 2011 and Updated 2011 Financial Guidance | 2 Nov 2011 |
| Articles of Association of Genmab A/S | 28 Oct 2011 |
| Arzerra Third Quarter 2011 Net Sales Figures | 26 Oct 2011 |